Logo image of LEG

LEGGETT & PLATT INC (LEG) Stock Fundamental Analysis

NYSE:LEG - New York Stock Exchange, Inc. - US5246601075 - Common Stock - Currency: USD

10.34  +0.19 (+1.87%)

After market: 10.34 0 (0%)

Fundamental Rating

3

Taking everything into account, LEG scores 3 out of 10 in our fundamental rating. LEG was compared to 67 industry peers in the Household Durables industry. Both the profitability and financial health of LEG have multiple concerns. LEG is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

LEG had positive earnings in the past year.
LEG had a positive operating cash flow in the past year.
LEG had positive earnings in 4 of the past 5 years.
In the past 5 years LEG always reported a positive cash flow from operatings.
LEG Yearly Net Income VS EBIT VS OCF VS FCFLEG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

1.2 Ratios

The Return On Assets of LEG (-21.77%) is worse than 90.77% of its industry peers.
LEG's Return On Equity of -111.07% is on the low side compared to the rest of the industry. LEG is outperformed by 92.31% of its industry peers.
With a Return On Invested Capital value of 7.79%, LEG perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for LEG is below the industry average of 12.03%.
Industry RankSector Rank
ROA -21.77%
ROE -111.07%
ROIC 7.79%
ROA(3y)3.53%
ROA(5y)4.48%
ROE(3y)11.01%
ROE(5y)14.95%
ROIC(3y)9.01%
ROIC(5y)9.04%
LEG Yearly ROA, ROE, ROICLEG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

1.3 Margins

The Operating Margin of LEG (5.96%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of LEG has declined.
LEG has a worse Gross Margin (17.51%) than 87.69% of its industry peers.
In the last couple of years the Gross Margin of LEG has declined.
Industry RankSector Rank
OM 5.96%
PM (TTM) N/A
GM 17.51%
OM growth 3Y-10.47%
OM growth 5Y-7.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.08%
GM growth 5Y-2.79%
LEG Yearly Profit, Operating, Gross MarginsLEG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so LEG is still creating some value.
LEG has more shares outstanding than it did 1 year ago.
LEG has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, LEG has a worse debt to assets ratio.
LEG Yearly Shares OutstandingLEG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
LEG Yearly Total Debt VS Total AssetsLEG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 2.62 indicates that LEG is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.62, LEG is in line with its industry, outperforming 41.54% of the companies in the same industry.
LEG has a debt to FCF ratio of 7.63. This is a slightly negative value and a sign of low solvency as LEG would need 7.63 years to pay back of all of its debts.
The Debt to FCF ratio of LEG (7.63) is comparable to the rest of the industry.
LEG has a Debt/Equity ratio of 2.13. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of LEG (2.13) is worse than 93.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.13
Debt/FCF 7.63
Altman-Z 2.62
ROIC/WACC1.01
WACC7.71%
LEG Yearly LT Debt VS Equity VS FCFLEG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.3 Liquidity

LEG has a Current Ratio of 1.48. This is a normal value and indicates that LEG is financially healthy and should not expect problems in meeting its short term obligations.
LEG's Current ratio of 1.48 is on the low side compared to the rest of the industry. LEG is outperformed by 76.92% of its industry peers.
A Quick Ratio of 0.84 indicates that LEG may have some problems paying its short term obligations.
LEG's Quick ratio of 0.84 is on the low side compared to the rest of the industry. LEG is outperformed by 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 0.84
LEG Yearly Current Assets VS Current LiabilitesLEG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2

3. Growth

3.1 Past

The earnings per share for LEG have decreased strongly by -27.63% in the last year.
Measured over the past years, LEG shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.01% on average per year.
The Revenue has decreased by -7.57% in the past year.
LEG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.05% yearly.
EPS 1Y (TTM)-27.63%
EPS 3Y-13.26%
EPS 5Y-11.01%
EPS Q2Q%-11.11%
Revenue 1Y (TTM)-7.57%
Revenue growth 3Y3.35%
Revenue growth 5Y2.05%
Sales Q2Q%-6.27%

3.2 Future

The Earnings Per Share is expected to grow by 3.32% on average over the next years.
Based on estimates for the next years, LEG will show a decrease in Revenue. The Revenue will decrease by -0.25% on average per year.
EPS Next Y-24.25%
EPS Next 2Y-7.7%
EPS Next 3Y-2.3%
EPS Next 5Y3.32%
Revenue Next Year-7.66%
Revenue Next 2Y-4.17%
Revenue Next 3Y-2.42%
Revenue Next 5Y-0.25%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LEG Yearly Revenue VS EstimatesLEG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
LEG Yearly EPS VS EstimatesLEG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.40, the valuation of LEG can be described as very reasonable.
67.69% of the companies in the same industry are more expensive than LEG, based on the Price/Earnings ratio.
LEG's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.47.
With a Price/Forward Earnings ratio of 8.73, the valuation of LEG can be described as very reasonable.
Based on the Price/Forward Earnings ratio, LEG is valued a bit cheaper than 70.77% of the companies in the same industry.
LEG is valuated cheaply when we compare the Price/Forward Earnings ratio to 92.74, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.4
Fwd PE 8.73
LEG Price Earnings VS Forward Price EarningsLEG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LEG is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LEG indicates a rather cheap valuation: LEG is cheaper than 93.85% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.64
EV/EBITDA 7.21
LEG Per share dataLEG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

LEG's earnings are expected to decrease with -2.30% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.7%
EPS Next 3Y-2.3%

5

5. Dividend

5.1 Amount

LEG has a Yearly Dividend Yield of 1.83%. Purely for dividend investing, there may be better candidates out there.
LEG's Dividend Yield is rather good when compared to the industry average which is at 2.94. LEG pays more dividend than 81.54% of the companies in the same industry.
LEG's Dividend Yield is comparable with the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 1.83%

5.2 History

The dividend of LEG has a limited annual growth rate of 4.04%.
LEG has been paying a dividend for at least 10 years, so it has a reliable track record.
LEG has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.04%
Div Incr Years33
Div Non Decr Years33
LEG Yearly Dividends per shareLEG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

The earnings of LEG are negative and hence is the payout ratio. LEG will probably not be able to sustain this dividend level.
The dividend of LEG is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-23.21%
EPS Next 2Y-7.7%
EPS Next 3Y-2.3%
LEG Yearly Income VS Free CF VS DividendLEG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

LEGGETT & PLATT INC

NYSE:LEG (2/4/2025, 8:04:00 PM)

After market: 10.34 0 (0%)

10.34

+0.19 (+1.87%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)10-28 2024-10-28/amc
Earnings (Next)02-13 2025-02-13/amc
Inst Owners78.59%
Inst Owner Change-1.18%
Ins Owners0.65%
Ins Owner Change0.46%
Market Cap1.39B
Analysts49.09
Price Target12.92 (24.95%)
Short Float %4.12%
Short Ratio2.93
Dividend
Industry RankSector Rank
Dividend Yield 1.83%
Yearly Dividend1.8
Dividend Growth(5Y)4.04%
DP-23.21%
Div Incr Years33
Div Non Decr Years33
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.37%
Min EPS beat(2)-3.49%
Max EPS beat(2)-3.26%
EPS beat(4)0
Avg EPS beat(4)-4.13%
Min EPS beat(4)-5.12%
Max EPS beat(4)-3.26%
EPS beat(8)1
Avg EPS beat(8)-0.02%
EPS beat(12)4
Avg EPS beat(12)2.03%
EPS beat(16)7
Avg EPS beat(16)5.85%
Revenue beat(2)0
Avg Revenue beat(2)-1.75%
Min Revenue beat(2)-2.07%
Max Revenue beat(2)-1.43%
Revenue beat(4)0
Avg Revenue beat(4)-1.5%
Min Revenue beat(4)-2.32%
Max Revenue beat(4)-0.17%
Revenue beat(8)1
Avg Revenue beat(8)-2.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.67%
Revenue beat(16)6
Avg Revenue beat(16)-0.26%
PT rev (1m)-5%
PT rev (3m)0%
EPS NQ rev (1m)-1.22%
EPS NQ rev (3m)-25.69%
EPS NY rev (1m)-0.24%
EPS NY rev (3m)-0.24%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-5.46%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.05%
Valuation
Industry RankSector Rank
PE 9.4
Fwd PE 8.73
P/S 0.31
P/FCF 5.64
P/OCF 4.21
P/B 1.87
P/tB N/A
EV/EBITDA 7.21
EPS(TTM)1.1
EY10.64%
EPS(NY)1.18
Fwd EY11.45%
FCF(TTM)1.83
FCFY17.74%
OCF(TTM)2.45
OCFY23.73%
SpS33.08
BVpS5.52
TBVpS-1.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.77%
ROE -111.07%
ROCE 10.15%
ROIC 7.79%
ROICexc 8.72%
ROICexgc 14.89%
OM 5.96%
PM (TTM) N/A
GM 17.51%
FCFM 5.54%
ROA(3y)3.53%
ROA(5y)4.48%
ROE(3y)11.01%
ROE(5y)14.95%
ROIC(3y)9.01%
ROIC(5y)9.04%
ROICexc(3y)9.91%
ROICexc(5y)9.88%
ROICexgc(3y)23.02%
ROICexgc(5y)23.67%
ROCE(3y)11.77%
ROCE(5y)11.79%
ROICexcg growth 3Y-7.57%
ROICexcg growth 5Y-6.76%
ROICexc growth 3Y-3.28%
ROICexc growth 5Y-10.81%
OM growth 3Y-10.47%
OM growth 5Y-7.79%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.08%
GM growth 5Y-2.79%
F-Score4
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 2.13
Debt/FCF 7.63
Debt/EBITDA 3.84
Cap/Depr 56.71%
Cap/Sales 1.87%
Interest Coverage 250
Cash Conversion 80.09%
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 0.84
Altman-Z 2.62
F-Score4
WACC7.71%
ROIC/WACC1.01
Cap/Depr(3y)58.65%
Cap/Depr(5y)57.1%
Cap/Sales(3y)2.15%
Cap/Sales(5y)2.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.63%
EPS 3Y-13.26%
EPS 5Y-11.01%
EPS Q2Q%-11.11%
EPS Next Y-24.25%
EPS Next 2Y-7.7%
EPS Next 3Y-2.3%
EPS Next 5Y3.32%
Revenue 1Y (TTM)-7.57%
Revenue growth 3Y3.35%
Revenue growth 5Y2.05%
Sales Q2Q%-6.27%
Revenue Next Year-7.66%
Revenue Next 2Y-4.17%
Revenue Next 3Y-2.42%
Revenue Next 5Y-0.25%
EBIT growth 1Y-25.18%
EBIT growth 3Y-7.47%
EBIT growth 5Y-5.9%
EBIT Next Year15.23%
EBIT Next 3Y8.3%
EBIT Next 5Y8.31%
FCF growth 1Y-14.75%
FCF growth 3Y-10.59%
FCF growth 5Y6.43%
OCF growth 1Y-14.46%
OCF growth 3Y-6.21%
OCF growth 5Y2.46%